je.st
news
Biotech Weekly: Stories To Track Into SABCS, Oncothyreon And Puma Biotechnology
2015-11-16 19:03:27| Biotech - Topix.net
After discussing Celsion Corporation in my first Stories To Watch Into SABCS, I will discuss upcoming data at SABCS for Oncothyreon and Puma Biotechnology in my second piece. I believe either notable ORR improvement for the ONT-380/T DM1 trial or continued display of promising efficacy trends in the brain metastases patient group could trigger a $5+pps for ONTY.
Tags: track
stories
weekly
biotech
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||